Editorial Board — Medscape Diabetes & Endocrinology

Board Members

  • Harpreet S. Bajaj. MD, MPH
    • Research Associate
      Leadership Sinai Center for Diabetes
      Mount Sinai Hospital
      University of Toronto
      Toronto, Ontario, Canada
      Associate Endocrinologist
      LMC Diabetes & Endocrinology
      Brampton, Ontario, Canada
  • Kenneth D. Burman, MD
    • Professor
      Department of Medicine
      Georgetown University School of Medicine
      Chief Endocrine Section
      Washington Hospital Center
      Washington, DC
  • Aaron R. Chidakel, MD
    • New York University Langone Medical Center
      New York, New York
  • Cyrus V. Desouza, MBBS
    • University of Nebraska Medical Center and Nebraska Medicine
      Omaha, Nebraska
  • Vivian Fonseca, MD
    • Tulane University
      New Orleans, Louisiana
  • Per-Henrik Groop, MD, DMSc
    • University of Helsinki
      Helsinki University Hospital
      Helsinki, Finland
  • Simon R. Heller, MB BChir, DM, FRCP
    • University of Sheffield School of Medicine
      Sheffield, South Yorkshire, United Kingdom
 

Board Member Details

Harpreet S. Bajaj, MD, MPH
Harpreet S. Bajaj, MD, MPH

Research Associate, Leadership Sinai Center for Diabetes, Mount Sinai Hospital; Endocrinologist, LMC Diabetes & Endocrinology, Brampton, Ontario, Canada

Harpreet S. Bajaj, MD, MPH, had disclosed the following relevant financial relationships:
Serve(d) as a speaker or a member of a speakers bureau for: Amgen; AstraZeneca; Boehringer Ingelheim; Janssen; Merck; Novo Nordisk; Sanofi
Received research grant from: AstraZeneca; Boehringer Ingelheim; Eli Lilly; Janssen; Merck; Novo Nordisk; Sanofi; Valeant
Received income in an amount equal to or greater than $250 from: Amgen; AstraZeneca; Boehringer Ingelheim; Canadian Collaborative Research Network; CMS Knowledge Translatoin; Diabetes Canada Scientific Group; Janssen; LMC Healthcare; mdBriefCase; Medscape; Meducom; Merck; Novo Nordisk; Sanofi-Aventis; Valeant

Kenneth D. Burman, MD

Professor, Department of Medicine, Georgetown University School of Medicine; Chief, Endocrine Section, MedStar Washington Hospital Center, Washington, DC

Kenneth D. Burman, MD, has disclosed the following relevant financial relationships:
Received research grant from: Exelixic; AstraZeneca; Institut Biochimique SA; Eisai
Received income in an amount equal to or greater than $250 from: UptoDate; American College of Physicians

Aaron R. Chidakel, MD
Aaron R. Chidakel, MD

Assistant Clinical Professor, New York University Langone Medical Center, New York, New York

Aaron R. Chidakel, MD, has disclosed no relevant financial relationships.

Cyrus V. Desouza, MBBS
Cyrus V. Desouza, MBBS

Professor, University of Nebraska Medical Center; Professor & Schulz Professor of Diabetes Research (Division Chief), Nebraska Medicine, Omaha, Nebraska

Cyrus V. Desouza, MBBS, has disclosed the following relevant financial relationships:
Serve(d) as a consultant for: Novo Nordisk

Vivian Fonseca, MD
Vivian Fonseca, MD

Professor of Medicine and Pharmacology; Assistant Dean for Clinical Research; Tullis-Tulane Alumni Chair in Diabetes; Chief, Section of Endocrinology, Tulane University Health Sciences Center, New Orleans, Louisiana

Vivian Fonseca, MD, has disclosed the following relevant financial relationships:
Receive(d) research support (to Tulane): Grants from Bayer HealthCare Pharmaceuticals; Boehringer Ingelheim Pharmaceutical Corporation
Received honoraria for consulting and lectures from: Takeda Pharmaceuticals North American, Inc.; Novo Nordisk; sanofi-aventis; Eli Lilly and Company; AstraZeneca Pharmaceuticals, LP; Intarcia; Asahi; Abbott
Has stock options in: Microbiome Technologies; Insulin Algorithms; BRAVO4Health
Has stock in: Amgen

Per-Henrik Groop, MD, DMSc

Professor of Internal Medicine, University of Helsinki; Chief Physician, Division of Nephrology, Helsinki University Hospital, Helsinki, Finland

Per-Henrik Groop, MD, DMSc, has disclosed the following relevant financial relationships:
Serve(d) as a consultant and on advisory boards for: AbbVie; Astellas; AstraZeneca; Boehringer Ingelheim; Cebix; Eli Lilly; Janssen; MundiPharma; MSD; Novartis; Novo Nordisk; Sanofi
Serve(d) as a speaker for: Astellas; AstraZeneca; Boehringer Ingelheim; Eli Lilly; Elo Water; Janssen; MundiPharma; MSD; Novartis; PeerVoice; Sanofi
Received research grant from: Eli Lilly; Roche
Received income in an amount equal to or greater than $250 from: AbbVie; Astellas; AstraZeneca; Boehringer Ingelheim; Cebix; Eli Lilly; Janssen; MundiPharma; MSD; Novartis; Novo Nordisk; Sanofi; Elo Water; PeerVoice; Roche

Simon R. Heller, MB BChir, DM, FRCP
Simon R. Heller, MB BChir, DM, FRCP

Professor of Clinical Diabetes, Department of Oncology and Metabolism, University of Sheffield School of Medicine; Honorary Consultant Physician, Department of Diabetes and Endocrinology, Sheffield Teaching Hospitals Foundation Trust, Sheffield, South Yorkshire, United Kingdom

Simon R. Heller, MB BChir, DM, FRCP, has disclosed the following relevant financial relationships:
Serve(d) as a director, officer, partner, employee, advisor, consultant, or trustee for: Eli Lilly; Novo Nordisk; Takeda; Boehringer Ingelheim; Sanofi Aventis
Serve(d) as a speaker or member of a speakers bureau for: Eli Lilly; Novo Nordisk

Akshay B. Jain, MD, FACE, CCD, ECNU, DABOM

Consultant Endocrinologist, Department of Endocrinology and Metabolism, Wockhardt Hospital, Fraser Riner Endocrinology, Vancouver, British Columbia, Canada

Askay B. Jain, MD, FACE, CCD, ENCU, DABOM, has disclosed the following relevant financial relationships:
Serve(d) as a speaker or member of a speakers bureau for AstraZeneca; Boehringer-Ingelheim; Eli Lilly; Janssen; Merck; Novo Nordisk; Sanofi Aventis

Scott Kahan, MD, MPH

Director, National Center for Weight and Wellness; Medical Director, S.T.O.P. Obesity Alliance; Faculty, Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University, Washington, DC

Scott Kahan, MD, MPH, has disclosed the following relevant financial relationships:
Serve(d) as a consultant for: Novo Nordisk; Orexigen; Vivus; iNova; Biologix; Amgen

Angela M. Leung, MD, MSc

Assistant Professor of Medicine, Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, UCLA David Geffen School of Medicine, Los Angeles, California

Angela M. Leung, MD, MSc, has disclosed the following relevant financial relationships:
Serve(d) as a director, officer, partner, employee, advisor, consultant, or trustee for: American Thyroid Association; Versar, Inc.; Mundipharma; Eastern Research Group; FivePrime Therapeutics
Serve(d) as a speaker or a member of a speakers bureau for: Medical Education Resources; ScientiaCME

Jessica Sparks Lilley, MD

Division Chief, Department of Pediatric Endocrinology, Mississippi Center for Advanced Medicine, Madison, Mississippi

Jessica Sparks Lilley, MD, has disclosed the following relevant financial relationships:
Serve(d) as a speaker or a member of a speakers bureau for: Insulet; AbbVie

Anne L. Peters, MD
Anne L. Peters, MD, CDE

Professor, Department of Clinical Medicine, Keck School of Medicine; Director, University of Southern California Westside Center for Diabetes, University of Southern California, Los Angeles, California

Anne L. Peters, MD, has disclosed the following relevant financial relationships:
Serve(d) on the advisory board for: Abbott Diabetes Care; Becton Dickinson; Boehringer Ingelheim Pharmaceuticals, Inc.; Eli Lilly and Company; Lexicon Pharmaceuticals, Inc.; Livongo; Medscape; Merck & Co., Inc.; Novo Nordisk; Omada Health; OptumHealth; sanofi; Zafgen
Received research support from: Dexcom; MannKind Corporation; Astra Zeneca
Serve(d) as a member of a speakers bureau for: Novo Nordisk

Arya M Sharma, MD, PhD, DSc (h.c.), FRCPC
Arya M Sharma, MD, PhD, DSc (h.c.), FRCPC

Professor of Medicine, University of Alberta; Physician, Edmonton Bariatric Specialty Clinic, Edmonton, Alberta

Arya M Sharma, MD, PhD, DSc (h.c.), FRCPC, has disclosed the following relevant financial relationships:
Serve(d) as a speaker or a member of a speakers bureau for: Novo Nordisk; Bausch

Dace L. Trence, MD
Dace L. Trence, MD

Professor, Department of Medicine; Director, Diabetes Care Center; Director, Endocrine Fellowship, University of Washington, Seattle

Dace Trence, MD, has disclosed the following relevant financial relationships:
Holds stock in: Medtronic, Inc.; Sanofi